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Slit/Roundabout (Robo) signaling controls midline repulsive axon guidance. However, proteins that interact with Slit/Robo at the cell
surface remain largely uncharacterized. Here, we report that the Drosophila transmembrane septate junction-specific protein Neurexin
IV (Nrx IV) functions in midline repulsive axon guidance. Nrx IV is expressed in the neurons of the developing ventral nerve cord, and nrx
IV mutants show crossing and circling of ipsilateral axons and fused commissures. Interestingly, the axon guidance defects observed in
nrx IV mutants seem independent of its other binding partners, such as Contactin and Neuroglian and the midline glia protein Wrapper,
which interacts in trans with Nrx IV. nrx IV mutants show diffuse Robo localization, and dose-dependent genetic interactions between nrx
IV/robo and nrx IV/slit indicate that they function in a common pathway. In vivo biochemical studies reveal that Nrx IV associates with
Robo, Slit, and Syndecan, and interactions between Robo and Slit, or Nrx IV and Slit, are affected in nrx IV and robo mutants, respectively.
Coexpression of Nrx IV and Robo in mammalian cells confirms that these proteins retain the ability to interact in a heterologous system.
Furthermore, we demonstrate that the extracellular region of Nrx IV is sufficient to rescue Robo localization and axon guidance pheno-
types in nrx IV mutants. Together, our studies establish that Nrx IV is essential for proper Robo localization and identify Nrx IV as a novel
interacting partner of the Slit/Robo signaling pathway.
Introduction
A common organizational principle among all organisms is that
the two halves of the CNS are interconnected by commissures in
which interneurons project across the midline (ML). In Drosoph-
ila CNS, many of these interneurons project axons across the ML
of the ventral nerve cord (VNC) in one of two distinct tracts: the
anterior commissure (AC) or the posterior commissure (PC),
each of which connects the opposing sides of the CNS (Goodman
and Doe, 1993; Jacobs, 2000). Collectively, axons extending from
multiple populations of contralaterally and ipsilaterally project-
ing interneurons follow stereotypic trajectories forming the con-
spicuous orthogonal array that represents the Drosophila VNC.
Specialized midline glia (MG) attract or repulse axons by secret-
ing ligands (Garbe and Bashaw, 2004, 2007; O’Donnell et al.,
2009). Netrin A and B are attractive glia-derived ligands that
interact with their respective neuronal receptors, Frazzled and
Unc5, respectively (Harris et al., 1996; Kolodziej et al., 1996;
Mitchell et al., 1996; Keleman and Dickson, 2001; Brankatschk
and Dickson, 2006; Garbe and Bashaw, 2007; Yang et al., 2009).
The repulsive axon guidance pathway comprises the glial ligand
Slit and the Robo family of transmembrane receptors (Seeger et
al., 1993; Kidd et al., 1998, 1999; Battye et al., 1999; Rajagopalan et
al., 2000; Simpson et al., 2000). Slit, Netrin, and their respective
neuronal receptors play critical roles in patterning axonal con-
nections in the developing nervous system ML across species.
Recent studies have shown that Slit and Netrin influence ML
axon crossing by both independent and interdependent signaling
by Robo and Frazzled (Garbe and Bashaw, 2007; Yang et al.,
2009).
The high fidelity of Slit/Robo interactions is evolutionarily
conserved; Drosophila Slit binds with mammalian Robo and vice
versa (Brose et al., 1999). How the interactions between secreted
Slit and Robo transduce signals intracellularly, and the proteins
involved in Slit/Robo interactions at the cell surface, remain un-
clear. Recently, the heparan sulfate proteoglycan (HSPG) Synde-
can (Sdc) was shown to form a molecular complex with Slit/
Robo. sdc mutants displayed axon guidance defects, but little is
known regarding the mechanisms that ensure Robo localization
and stabilization and its interactions with Slit at the cell surface
(Johnson et al., 2004; Steigemann et al., 2004; Chanana et al.,
2009). Studies by Dickson and colleagues have shown that Com-
missureless controls axon guidance across the Drosophila midline
by regulating trafficking and therefore the cell surface levels of the
Robo protein (Keleman et al., 2002, 2005). A better understand-
ing of the intracellular molecular events occurring within axons
has emerged from Drosophila and mammalian studies (Fritz and
VanBerkum, 2000, 2002; Fan et al., 2003; Yang and Bashaw,
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2006). It is conceivable that additional coreceptors or accessory
proteins participate in presenting and/or stabilizing the secreted
axon guidance factors for efficient and controlled signal trans-
duction to allow the growing axons to navigate to their final
destination.
Recent studies from our laboratory and others revealed that
Neurexin IV (Nrx IV) is expressed in ML neurons and interacts in
trans with MG protein Wrapper to organize the neuron– glial
scaffold (Stork et al., 2009; Wheeler et al., 2009). Here we report
novel and distinct functions of Nrx IV in axon guidance at the
embryonic ML that are independent of its binding partners, Con-
tactin, Neuroglian, and Wrapper. Our studies establish that Nrx
IV is essential for proper Robo localization and repulsive axon
guidance and thus identify Nrx IV as a novel interacting compo-
nent of the Robo/Slit signaling pathway.
Materials and Methods
Drosophila stocks and molecular biology reagents. The Drosophila mutants
used in this study are: nrx IV4304 (Baumgartner et al., 1996), roboGA285
(Kidd et al., 1998), slit2 (Rothberg et al., 1990), nrg1, contex956 (Faivre-
Sarrailh et al., 2004), wrapper175 (Noordermeer et al., 1998), sdc10608,
Df48ubi-Sara (Johnson et al., 2004), fra3, fra4, and netA,B (Andrews et al.,
2008). The Gal4 and UAS lines used are as follows: UAS-nrx IVmyc, UAS-
nrx IVmycCT, UAS-nrx IVmycNT (this study), UAS-tau GFP (Brand,
1995); elav-Gal4, sim-Gal4, repo-Gal4, ap-Gal4, and nrx IV:GFP
(CA06597) (Buszczak et al., 2007) obtained from Bloomington Stock
Center and the FlyTrap project. For expression of robo and slit in mam-
malian HEK 293 and Chinese hamster ovary (CHO) cells, the respective
cDNAs were cloned into pcDNA3.1 (Invitrogen) and expressed using
standard cell culture experiments. Expression of nrx IV and cont in mam-
malian cells has been previously reported (Faivre-Sarrailh et al., 2004).
Immunofluorescence of embryos and mammalian cells. Antibody stain-
ing of embryos was done as previously described (Banerjee et al., 2006).
Primary antibodies used were as follows: rabbit anti-Nrx IV (1:500), rat
anti-Wrapper (1:250; Wheeler et al., 2009), chicken anti-GFP (1:500,
Invitrogen), monoclonals including anti-Fasciclin II (anti-Fas II) (ID4,
1:250), BP102 (1:500), anti-Robo (13C9, 1:10), and anti-Slit (C555.6D,
1:50), which were obtained from the Developmental Studies Hybridoma
Bank, University of Iowa. Isotype-specific and fluorescent secondary anti-
bodies Alexa 488, 568, and 647 were obtained from Jackson Immunochemi-
cals and Invitrogen. The Zenon mouse IgG1 labeling kit (Invitrogen) was
used for colocalization studies of Fas II and Robo according to the man-
ufacturer’s instructions.
CHO K1 and HEK 293 cells were obtained from the Lineberger Com-
prehensive Cancer Center (University of North Carolina Chapel Hill,
Chapel Hill, NC) and maintained in DMEM supplemented with 10%
fetal bovine serum, penicillin, and streptomycin in a humidified incuba-
tor at 37°C with 5% CO2. Cells (1.0  10
6) were plated on coverslips in 60
mm dishes, and after 24 h they were transfected with Fugene6 (Roche
Diagnostics) according to the manufacturer’s instructions. Following a
48 h incubation, cells were washed twice in PBS and fixed in a freshly
prepared 4% solution of formaldehyde in PBS. Cells were then washed
with PBS, extracted with 2% Triton X-100 (Sigma-Aldrich) in PBS for 10
min, washed again, and blocked in 5% normal donkey serum (Jackson
ImmunoResearch) in PBS for 2 h at 25°C. Cells were stained with pri-
mary antibody diluted in 5% bovine serum albumin (BSA Fraction V,
Sigma-Aldrich) in PBS overnight at 4°C. Antibody dilutions were iden-
tical to those used for Drosophila embryos. Following primary antibody
incubation, cells were washed three times for 15 min each with PBS/BSA
and subsequently incubated with 1:100 dilution of affinity-purified Cy2-
conjugated donkey anti-rabbit (Nrx IV) and a 1:500 dilution of Cy3-
conjugated donkey anti-mouse (Jackson ImmunoResearch) for 2 h at
25°C. Cells were washed as described above and mounted in Mowiol
(Calbiochem) with 1% n-propylgallate (Sigma-Aldrich). Wherever nec-
essary, the immunofluorescence images were captured under identi-
cal settings with a Z-step of 0.25 m for embryos and 0.2 m for CHO
cells on a Bio-Rad Radiance confocal microscope and processed with
Adobe PhotoShop software.
Statistical analyses of axon guidance defects. Four hundred abdominal
segments from 50 embryos of various genotypes at stage 16 were exam-
ined for aberrant axon crossings at the ML. Data are presented as average
number of ML crossings per embryo for each genotype. All genotypes
were analyzed using ANOVA and error bars indicate SEM. * indicates a p
value of 0.05, ** indicates a p value of 0.01, and *** indicates a p value
of 0.001.
Collection of homozygous mutant embryos. nrx IV, robo, and slit mu-
tants were balanced with balancer chromosomes carrying twi-GFP, and
the respective homozygous mutant embryos were automatically sorted
with the Complex Object Parametric Analyzer and Sorter (COPAS) Se-
lect embryo sorter (Union Biometrica) by their lack of GFP expression
according to published procedures (Furlong et al., 2001). The efficiency
and quality of the sorted non-GFP mutant embryos were visually in-
spected for any GFP-positive embryos by using a GFP microscope and
found to be close to 100%, and if any contaminating GFP-positive em-
bryos were seen, they were manually removed. Wild-type Canton S em-
bryos were identically processed through the sorting procedure and used
as controls. All protein estimations in lysates were performed using the
DC Bio-Rad assay.
Drosophila S2 cell culture and RNAi. Drosophila S2 cell culture and
RNAi were performed as described in the study by Rogers and Rogers
(2008). Templates for in vitro transcription were generated by PCR
with the primers encoding the T7 promoter sequence upstream of
the following: slit (5-TGCTCATCTTGCAGTGGAAC-3 and 5-
CTTCATGCAGCCCTTAAAGC-3). The efficiency of RNAi was de-
termined by immunoblotting of S2 lysates with the Slit monoclonal
antibody C555.6D. Overall protein amounts loaded for immunoblot-
ting were normalized after estimation and verified using anti--
tubulin antibodies.
Immunoprecipitation and immunoblotting. Embryos of desired geno-
types were homogenized using a glass homogenizer in a weight/volume
ratio of 1:4 in ice-cold lysis buffer containing 50 mM HEPES, pH 7.2, 100
mM NaCl, 1 mM MgCl2, 1 mM CaCl2 and 1% NP-40 with protease inhib-
itors. HEK 293 cells were washed with PBS and lysed in 250 l of lysis
buffer. The lysates were kept on ice for 30 min and centrifuged at
15,000  g for 30 min at 4°C, followed by recentrifugation, and used
subsequently for immunoprecipitation (IP). For each IP reaction, 100 l
of supernatant was precleared with Protein A or G beads followed by
incubation with primary antibodies at 1:20 dilution (anti-Nrx IV, anti-
Slit, anti-Robo, and anti-Sdc) for 8 h at 4°C. The supernatant–antibody
mix was incubated with 25 l of prewashed Protein A or G beads for 2 h
at 4°C. The beads were then washed three times in PBS followed by
elution of the immunocomplexes in 30 l of PBS/SDS buffer and re-
solved by SDS-PAGE for immunoblotting with respective antibodies. IP
data presented below (see Figs. 6 B–G, L, M, 7K–P) were performed using
identical experimental conditions.
Results
Ipsilateral axons cross the midline and commissures fail to
separate in nrx IV mutants
We have previously established the role of Nrx IV in septate junc-
tion (SJ) organization (Baumgartner et al., 1996; Faivre-Sarrailh
et al., 2004; Banerjee et al., 2006, 2008). However, apart from this
traditional role of Nrx IV in junctional organization and func-
tion, additional roles of Nrx IV in the developmental organiza-
tion of the embryonic ML have begun to emerge (Stork et al.,
2009; Wheeler et al., 2009). In the present study, we analyzed the
precise subcellular localization of Nrx IV in the developing CNS
of wild-type embryos together with two well known monoclonal
antibody markers, ID4 (against Fas II) and BP102. Immunostain-
ing of wild-type (/) embryos from stage 12 through late 16/17
with antibodies against Nrx IV, Fas II, and BP102 (Fig.
1A,C,E,G,I) shows that at stage 12 Nrx IV is expressed in the
central group of cells also stained by Fas II, namely, the cluster of
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two sibling neurons, anterior corner cell (aCC) and posterior
corner cell (pCC). Nrx IV localization is strong in the aCC (Fig.
1Aa, arrowhead), pCC, and the SP1 pioneer neurons (Fig. 1Aa,
arrow). Nrx IV is also localized to the two ML precursor (MP) 1
and MP2 pioneer neurons as revealed by staining with Odd
skipped and 22c10 antibodies (data not shown). At subsequent
stages 13, 14, 15, and late 16/17 (Fig. 1Ca,Ea,Ga,Ia, respectively),
Nrx IV neuronal expression becomes more refined with distinct
localization in the ML. Nrx IV is uniformly distributed through-
out the lateral CNS neurons and is expressed at lower levels in the
axons (Fig. 1 Ia). The axonal expression of Nrx IV with nrx IV:
GFP exon-trap line shows prominent GFP expression in axons of
both commissures and longitudinal connectives (LCs) (Fig. 1Ka,
arrows), indicating that Nrx IV is expressed in the CNS axons.
Having established the wild-type localization of Nrx IV in the
developing CNS, we next examined the consequences of loss of
Nrx IV in the CNS with Fas II and BP102 antibodies as a pheno-
typic readout. As expected, nrx IV mutant embryos display com-
Figure 1. Nrx IV is required for midline axon guidance. A–L, Wild-type (A, C, E, G, I ), nrx IV mutant (B, D, F, H, J ), nrx IV-GFP (K ), and elav-Gal4::UAS-nrx IVmyc; nrx IV / (L) embryos stained
with Nrx IV, Fas II, and BP102 (A–J, L), and GFP, Fas II, and BP102 (K ). All panels show ventral views with anterior up and the optical focus is on the Fas II and BP102 axonal projections. A, Stage 12
(s12) wild-type embryo shows Nrx IV localization in cell bodies of aCC (Aa, arrowhead), SP1 (arrow) and lower levels in axons. Fas II (Ab) is expressed in pCC growth cone (arrow) and BP102 (Ac) labels
most CNS axons and the commissures. B, Similar-stage nrx IV embryo shows loss of Nrx IV (Ba), Fas II (arrow, Bb), and BP102 (Bc) expression resembling the wild-type embryo (Ac). C, D, Stage 13
(s13) wild-type (C) and nrx IV (D) embryos show localization of Nrx IV (Ca, Da), Fas II (Cb, Db), and BP102 (Cc, Dc). E, Stage 14 (s14) wild-type embryo shows more refined Nrx IV localization
concentrated in the boundaries between neurons and MG and lateral CNS (Ea). Fas II expression (Eb) shows that the two axon pathways, namely, pCC/dMP2 and MP1/dMP2, are fused at the segment
boundary (arrow). BP102 labels the CNS axons (Ec). F, Stage 14 nrx IV embryo (Fa) shows the pCC axon pathway extending anterior and toward the ML (Fb, arrow). The CNS axon profiles shown with
BP102 (Fc) display partially fused commissures (Fc, arrow). G, Stage 15 (s15) wild-type embryo shows Nrx IV localization in neurons and axons (Ga), refinement of Fas II-labeled tracts (Gb, arrow),
and overall CNS axon scaffold (Gc). H, Stage 15 nrx IV mutant shows increased attraction of the ipsilateral tracts toward the ML (Hb, arrow) and BP102 shows increasingly fused AC and PC (Hc, arrows)
in most segments. I, Late-stage 16/17 (s16) wild-type embryo shows Nrx IV expression (Ia) together with Fas II that labels three distinct longitudinal axon trajectories (Ib, arrow) and BP102 (Ic).
J, nrx IV mutant at a similar stage shows inappropriate crossing (Jb, arrows) and circling (Jb, arrowhead) of the innermost Fas II tract (Ja, arrows) and fused commissures (Jc, arrowheads). K, nrx
IV-GFP embryo shows distinct axonal localization of GFP (Ka) in addition to Fas II (Kb) and BP102 (Kc). L, An elav-Gal4::UAS-nrxIV;nrxIV / embryo shows expression of Nrx IV (La) in all
elav-Gal4-positive cells and rescue of Fas II (Lb, arrows)- and BP102 (Lc)-labeled axons in two of the displayed segments (Ld). M, Quantification of axon crossing from 400 abdominal segments of
wild-type, nrx IV and elav-Gal4::UAS-nrx IVmyc;nrxIV /, repo-Gal4::UAS-nrx IVmyc;nrx IV /, and sim-Gal4::UAS-nrx IVmyc;nrx IV / mutant embryos. Statistically significant rescue of axon
crossing defects is observed only in elav-Gal4::UAS-nrx IVmyc;nrxIV / embryos ( p  0.001) compared with nrx IV mutants.
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plete loss of Nrx IV protein (Fig. 1Ba,Da,Fa,Ha,Ja) (Banerjee et
al., 2008). At stage 12, Fas II is expressed in aCC and pCC neurons
(Fig. 1Ab) and in the anterior extending growth cone of pCC
(Fig. 1Ab, arrow). The commissures at this stage are clearly es-
tablished but appear fused at the ML (Fig. 1Ac). In a similar-stage
nrx IV mutant embryo, the Fas II and BP102 staining is compa-
rable to the wild-type embryo (Fig. 1Bb–Bd). A stage 13 wild-type
embryo (Fig. 1Cb) expresses Fas II in additional axons, including
MP1, dMP2, and vMP2, all of which fasciculate in the MP1 path-
way. BP102 staining reveals further separations of AC and PC as
the middle MG becomes intercalated between the two commis-
sures (Fig. 1Cc) (Klämbt et al., 1991). In stage 13 nrx IV mutant
embryos, no significant differences in the Fas II-expressing axons
are noted (Fig. 1Db) but the BP102 pattern in nrx IV mutant
embryo shows that commissural separation is not occurring nor-
mally (Fig. 1Dc). Stage 14 wild-type embryos express Fas II in the
pCC pathway, which is continuous from segment to segment
(Fig. 1Eb, arrow) along the entire length of the CNS. The AC and
PC show greater separation as revealed by BP102 staining at this
stage (Fig. 1Ec). At stage 14 nrx IV mutants begin to exhibit
defects in Fas II localization. The pCC pathway becomes attracted
toward the ML (Fig. 1Fb, arrow) and commissure separation is
further affected (Fig. 1Fc, arrow). The axonal phenotypes as re-
vealed by both Fas II and BP102 become more pronounced as the
nrx IV mutant embryos develop. At stage 15, wild-type embryos
show refinement of the ipsilateral Fas II tracts (Fig. 1Gb, arrow),
while nrx IV mutant embryos show crossing of the most medial
Fas II-positive pCC trajectory (Fig. 1Hb, arrow) and thicker com-
missures (Fig. 1Hc, arrow) compared with the wild-type embryos
(Fig. 1Gc). Embryonic stage 16 marks the completion of entire
axon scaffold formation in the CNS. By late stage, i.e., stage 16/17,
wild-type embryos show Fas II expression at high levels on three
longitudinal axon bundles on either side of ML (Fig. 1 Ib, arrows).
BP102, on the other hand, labels all CNS axons, including the
commissural and longitudinal pathways. nrx IV mutants at stage
16 and beyond show the most striking axonal phenotypes, which
include crossing (arrows) and often circling of Fas II-positive
ipsilateral axons in the ML (Fig. 1 Jb, arrowhead) and thinning of
LCs together with the failure of the AC and PC to separate, result-
ing in partially to completely fused commissures (Fig. 1 Jc, arrow-
heads). These phenotypes are similar to those observed in robo
mutants (Kidd et al., 1998). To demonstrate that the axon guid-
ance defects observed in nrx IV mutant CNS are due to loss of nrx
IV in neurons, we used the pan-neural elav-Gal4 line to drive
UAS-nrx IVmyc in nrx IV mutant background. Stage 16 embryos
mutant for nrx IV and carrying elav-Gal4::UAS-nrx IVmyc ana-
lyzed using Nrx IV (Fig. 1La), Fas II (Fig. 1Lb), and BP102 (Fig.
1Lc) antibodies showed rescue of the axonal phenotypes (Fig.
1Ld,M), indicating that loss of Nrx IV from the CNS neurons
results in axon guidance defects. Expression of Nrx IV myc either
in all ML cells (glia and neurons) with sim-Gal4 or in all lateral
glia with repo-Gal4 failed to rescue the axon crossing phenotypes
in nrx IV mutants, suggesting that these CNS cell types do not
contribute to the axon guidance phenotypes observed in nrx IV
mutants (Fig. 1M).
We further show that absence of Nrx IV results in loss of ML
repulsion by studying the Apterous (Ap)-positive neurons and
their ipsilaterally projecting axons in the CNS in nrx IV mutants
(Lundgren et al., 1995) (supplemental Fig. S1, available at www.
jneurosci.org as supplemental material). We find that in nrx IV
mutants, the Ap neurons extend axons that display pathfinding
errors, including misrouting across the ML in most of the seg-
ments (supplemental Fig. S1, available at www.jneurosci.org as
supplemental material). Together, these results demonstrate that
loss of Nrx IV results in loss of axonal repulsion at the ML.
Nrx IV function in axon guidance is independent of Wrapper,
Contactin, and Neuroglian
Our earlier studies have shown that Nrx IV interacts with Ig
superfamily proteins such as Cont, Nrg, and Wrapper (Faivre-
Sarrailh et al., 2004; Banerjee et al., 2006; Wheeler et al., 2009).
Nrx IV, Cont, and Nrg are required for the formation and main-
tenance of epithelial and axo-glial SJs (Faivre-Sarrailh et al., 2004;
Banerjee et al., 2006). Nrx IV and Wrapper function in ensheath-
ment of commissural axons in the CNS and in the maintenance of
the midline neuron– glial scaffold (Wheeler et al., 2009). We
wanted to test whether any of these interacting partners of Nrx IV
displayed axon guidance phenotypes as observed in nrx IV mu-
tants. cont and nrg mutants did not display axon crossing defects
when stained with anti-Fas II (supplemental Fig. S2, available at
www.jneurosci.org as supplemental material). Immunostaining
of the wild-type embryos from stage 12 through 17 (Fig. 2A–F)
show localization of Nrx IV (green) and Wrapper (red) in the
developing CNS midline, in which Nrx IV in the midline neurons
localizes asymmetrically in juxtaposition to Wrapper in MG (Fig.
2A–F, arrowheads) (Stork et al., 2009; Wheeler et al., 2009). In
addition, Nrx IV expression is also observed in the lateral CNS
neurons and axons (Fig. 2Ac,Ec, arrows). To determine whether
wrapper mutants displayed axon guidance defects, wild-type (Fig.
2G) and wrapper mutant (Fig. 2H) embryos were triple immu-
nostained with Wrapper, Fas II, and BP102 antibodies. The wild-
type embryos show normal localization of Wrapper in MG (Fig.
2Ga, green), ipsilateral projections of Fas II-positive axons (Fig.
2Gb, red) and BP102 labeling of the CNS axons (Fig. 2Gc, blue)
and together in the merged image (Fig. 2Gd). Similar-stage wrap-
per mutant embryos (Fig. 2H) do not display any significant axon
guidance defects when labeled with anti-Fas II (Fig. 2Hb, red)
and BP102 (Fig. 2Hc, blue). These studies reveal that the axon
guidance functions of Nrx IV are independent of its known bind-
ing partners Cont, Nrg, and Wrapper.
Robo is diffusely distributed in longitudinal and commissural
axons of nrx IV mutants
Since nrx IV mutants display crossing and circling of ipsilateral
axons together with collapse of commissural axons at the ML,
and because the axon guidance function of Nrx IV is independent
of its binding partners Wrapper (Fig. 2), Contactin, and Neuro-
glian (supplemental Fig. S2, available at www.jneurosci.org as
supplemental material) (Noordermeer et al., 1998; Faivre-
Sarrailh et al., 2004), we reasoned that Nrx IV might partner with
other proteins for its axon guidance function in the ML. Axon
guidance in the ML can be regulated both by attractive and re-
pulsive cues (Garbe and Bashaw, 2007; Yang et al., 2009). We
examined the localization of Nrx IV in netrin and frazzled mu-
tants (supplemental Fig. S3, available at www.jneurosci.org as
supplemental material) and did not find any striking anomaly in
Nrx IV localization or a similarity in its axonal guidance pheno-
types. Given that nrx IV axon guidance phenotypes resemble that
of the robo mutants (Kidd et al., 1998), we hypothesized that Nrx
IV most likely functions in the Slit/Robo repulsive signaling path-
way (Brose et al., 1999; Kidd et al., 1999; Fan et al., 2003). There-
fore, we first examined the localization patterns of Nrx IV and
Robo in the wild-type embryo and nrx IV and robo mutants (Fig.
3) to determine whether these two proteins are interdependent
for their localization in the CNS.
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Robo expression in stage 12 wild-type embryos is seen on the
growth cones, which project ipsilaterally (Kidd et al., 1998). Little
or no Robo is observed on commissural axons as they extend
toward and across the ML. However, earlier work has shown that
as the commissural growth cones turn to project longitudinally,
their level of Robo expression dramatically increases (Kidd et al.,
1998). During stages 14 –16 of embryonic development, Robo
continues to be expressed at high levels on all longitudinally pro-
Figure 2. Developmental expression and localization of Nrx IV and Wrapper in the CNS midline and axon guidance in wrapper mutants. All panels shown are the ventral view with anterior up. In
panels A–F, the optical focus is at the MG–neuron interface. A–F, Wild-type embryos of stages 12 (A), 13 (B), 14 (C), 15 (D), 16 (E), and 17 (F ) showing localization of Nrx IV (green, Aa, Ba, Ca, Da,
Ea, Fa) and Wrapper (red, Ab, Bb, Cb, Db, Eb, Fb) in the developing CNS midline. Nrx IV shows a strong asymmetric localization (white arrowheads) in juxtaposition to Wrapper localization in the
MG (Ac, Bc, Dc, Ec, Fc). Arrows in Ac and Ec show expression of Nrx IV in axons and lateral CNS neurons. Red arrowhead in Ac indicates Wrapper localization at MG interface, whereas Nrx IV and
Wrapper are at the MG/ML neuron interface (Wheeler et al., 2009). G, Stage 16 wild-type embryos show Wrapper localization in MG (Ga) and axonal profile with anti-Fas II (Gb) and BP102 (Gc) and
in merged image (Gd). H, Stage 16 wrapper mutants (Ha) shows no detectable Wrapper protein as expected (Ha) and display normal trajectories of axonal profiles with no noticeable axon guidance
defects, as is evident from staining with anti-Fas II (Hb) and BP102 (Hc) and in merged image (Hd).
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Figure 3. Localization of Nrx IV and Robo in nrx IV and robo mutants. All panels show ventral views with anterior up. A–I, Stage 14 wild-type embryo with Nrx IV (Aa) and Robo (Ab) expression
in the CNS. Axonal staining of Nrx IV overlaps with high levels of Robo in longitudinal axons (Ac). B, C, Increased Robo localization is seen on contralateral axon tracts in stage 14 nrx IV mutants (B,
arrow), while Nrx IV localization in robo mutant is mildly affected and localizes more in lateral CNS neuronal cell bodies (C, arrows). D, Stage 15 wild-type embryo shows Nrx IV (Da) and Robo (Db)
expression with Robo at a higher level in axons, while a lower level is detected in the commissures (Db, arrowhead). E, Stage 15 nrx IV embryos show uniform Robo distribution in commissural and
longitudinal axons (arrow). F, Nrx IV shows increased localization in cell bodies of robo mutants (arrows) compared with a similar stage in the wild-type embryo (Da). G, Stage 16 wild-type embryo
continues to show Nrx IV and Robo expression overlapping in the longitudinal axons (Ga, Gb, arrows). Arrowhead in Gb points to low level of Robo detected in the commissures. H, Stage 16 nrx IV
embryos show uniformly diffuse distribution of Robo in the longitudinal and commissural axons (arrows). I, Nrx IV localization appears to be increased in cell bodies in robo mutants at a similar stage
(arrows). J, Wild-type embryos show Nrx IV (Ja), Robo (Jb), and Fas II (Jc) expression. K, nrx IV embryos show absence of Nrx IV (Ka), crossing of Robo-positive axons at the ML (arrows), and a
uniformly diffused localization of Robo in both the longitudinal and the commissural tracts (Kb, asterisks). Fas II-labeled axons cross at multiple segments in the ML (Kc, arrows), and display a
complete fusion of both of the innermost tracts (Kc, double arrows). L, Nrx IV shows increased distribution in neuronal cell bodies (arrows) in robo mutants (La) compared with a similar stage in the
wild-type embryo (Ja). Fas II labeling shows multiple crossing and circling of axons and fused innermost tracts (Lc, double arrows) similar to nrx IV mutants (Kc).
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jecting growth cones and axons and at low levels on commissural
axons (Fig. 3Ab,Db,Gb, respectively). Nrx IV localization in
stages 14 –16 (Fig. 3Aa,Da,Ga) is as described in Figure 1. Robo
and Nrx IV expression overlaps in the longitudinal axons of the
lateral CNS as seen in the merged image (Fig. 3Ac,Dc,Gc). Robo
localization in nrx IV mutants or vice versa at embryonic stages 12
and 13 resembles the wild-type localization (data not shown).
Starting around stage 14, nrx IV mutants display Robo localiza-
tion in crossing axons (Fig. 3B, arrow). At stages 15 and 16, nrx IV
mutants show diffuse Robo distribution in commissural and lon-
gitudinal axon tracts (Fig. 3E,H, arrows, Kb). Similarly, in robo
mutants at stages 14 through 16, Nrx IV displays aberrant distri-
bution in both the ML and lateral CNS and is observed more in
neuronal cell bodies (Fig. 3C,F, I, arrows) compared with the
wild-type embryos at similar stages of development (Fig.
3Aa,Da,Ga). These data indicate that Nrx IV and Robo are de-
pendent on each other for their proper localization in the CNS.
To further investigate the Robo localization with respect to
misguided Fas II-positive axons in nrx IV mutants, we studied the
coexpression of Robo and Fas II (Fig. 3J–L). Robo localization in
the wild-type embryos (Fig. 3Jb) is at high levels on the longitu-
dinal tracts on either side of the ML. Fas II-positive axons (Fig.
3Jc) show normal ipsilateral axon trajectories in the wild-type
embryos. In nrx IV mutants, however, Fas II-labeled axons cross
the ML at several segments (Fig. 3Kc, arrows) and often display a
complete collapse of the two innermost axon tracts at the ML as is
seen in robo mutants (Fig. 3Kc,Lc, double arrows). Interestingly,
the distribution of Robo in nrx IV mutants appears diffuse and
uniform in both the longitudinal and commissural tracts (Fig.
3Kb, arrows and asterisks). We further noticed two aspects of
Robo phenotype in nrx IV mutants with respect to Fas II. First,
Robo-positive tracts in few segments cross and seem to collapse at
the ML, in which Fas II-labeled axons do not cross. Second, in the
majority of other segments in which the Fas II ipsilateral axons
cross the ML, Robo-positive axons also show increased crossing
and a more pronounced collapse at the ML. These studies further
confirm that Robo localization is dependent on Nrx IV as evi-
denced by the uniformly diffuse distribution of Robo in longitu-
dinal tracts and commissures regardless of whether Fas II axons
cross or not. In robo mutants Nrx IV localization is also altered
and more Nrx IV is observed in neuronal cell bodies (Fig. 3La,d,
arrows).
nrx IV exhibits dose-dependent genetic interactions
with robo
Dosage-sensitive genetic interactions between two loci are a good
indicator that the proteins are functionally related. We therefore
tested for genetic interactions between robo and nrx IV. We ex-
amined the CNS of embryos transheterozygous or homozygous
for nrx IV and robo by generating roboGA285/CyO;nrx IV4304/TM6
flies. The wild-type embryos, single mutants, and combinations
of robo and nrx IV mutants were immunostained against Nrx IV
and Robo to identify mutant genotypes. Fas II (Fig. 4A–G) and
BP102 (Fig. 4H–N) served as the phenotypic readout of the axonal
defects at the ML in stage 16 embryos. In wild-type embryo, Fas II
labels three parallel axon fascicles that do not cross the ML (Fig. 4A).
nrx IV mutants show crossing of the innermost Fas II trajectory
(Fig. 4B, arrow), often resembling the robo mutants (Fig. 4C,
arrow). robo/;nrx IV/ transheterozygotes also display ML
crossing of Fas II that is significantly higher than that of either nrx
IV/ or robo/ heterozygotes (Fig. 4D, arrow, O). This dosage-
dependent transheterozygous phenotype is a strong indication
that Nrx IV and Robo interact directly and function in the same
pathway. The Fas II phenotype of homozygous nrx IV mutants is
significantly enhanced by removing one copy of robo (Fig. 4E,
arrows) while loss of one copy of nrx IV from robo homozygous
mutants (Fig. 4F) does not significantly enhance the robo mutant
phenotype (compare with Fig. 4C,O). Double mutant robo/;
nrx IV/ embryos showed phenotypes that resembled robo mu-
tant (Fig. 4G). Some robo/;nrx IV/ embryos occasionally
displayed more severe defects but the severity of defects in Fas II
tracts was not statistically significant compared with robo single
mutants (compare with Fig. 4C,O). Quantitative analyses of the
Fas II phenotypes (Fig. 4A–G) clearly highlight a dose-dependent
genetic interaction between the two loci (Fig. 4O).
We next studied the overall axon profile in the CNS of embryos
from each of the above genotypes (Fig. 4H–N) by staining with
BP102. In wild-type embryos the BP102-labeled axon scaffold ex-
hibits a characteristic ladder-like appearance (Fig. 4H). nrx IV mu-
tants show partial to complete fusion of commissures in most
segments and comparatively thinner LCs (Fig. 4I, arrows). robo mu-
tants show a severe disruption of the CNS axon scaffold with
thicker AC and PC and thinner LCs (Fig. 4 J, arrows) (Seeger et
al., 1993; Kidd et al., 1998). We next analyzed axonal phenotypes
in embryos heterozygous for robo and nrx IV (Fig. 4K); embryos
lacking one copy of robo and two copies of nrx IV (Fig. 4L);
embryos missing two copies of robo and one copy of nrx IV (Fig.
4M); and embryos double mutant for robo and nrx IV (Fig. 4N).
As seen in Figure 4K, transheterozygotes of robo and nrx IV show
4 –5% of segments with a mild reduction in the intercommissural
distance and reduced spacing between the LCs compared with the
wild-type embryos (Fig. 4H). The effect of removing one copy of
robo in nrx IV mutants resulted in a dominant enhancement of
BP102 phenotype compared with nrx IV mutants alone (Fig. 4,
compare L with I). However, removal of one copy of nrx IV from
robo mutant embryos did not cause significant aggravation of the
BP102 phenotype (Fig. 4M) compared with robo-null mutants
(Fig. 4 J). robo, nrx IV double mutant embryos displayed a col-
lapse of commissures (Fig. 4N). These data indicate a range of
axonal phenotypes that includes significantly thicker commis-
sures, reduced to sometimes missing parts of LC in various geno-
types, strongly indicating a loss of ML repulsion. Together, these
studies demonstrate dosage-sensitive genetic interactions be-
tween nrx IV and robo, providing evidence that they function
together in repulsive axon guidance pathway.
We also studied Robo localization with respect to other ipsilateral
trajectories such as Ap-positive axons. Robo (Fig. 4Pa) and Ap-positive
axons labeled by GFP (Fig. 4Pb) in ap-Gal4::UAS-tau-GFP embryo
show Robo localization as described in Figure 3, while Ap axons show
normal ipsilateral axon trajectories. In ap-Gal4::UAS-tau-GFP;nrx
IV/ embryos Robo show diffuse localization in LCs and com-
missures (Fig. 4Qa), while the GFP-labeled Ap axons also cross
the ML (Fig. 4Qb, arrows), further suggesting that different
classes of ipsilateral axons are influenced by loss of ML repulsion
in nrx IV mutants.
nrx IV exhibits dose-dependent genetic interactions with slit
The well established role of Slit as a ligand for Robo receptors in
repulsive axon guidance led us to hypothesize that Nrx IV might
also interact with Slit. We thus determined whether or not Nrx
IV, Slit, and Robo are interdependent for their proper localiza-
tion and/or function. Immunofluorescent labeling of stage 16
wild-type embryos with Nrx IV (Fig. 5Aa), Slit (Fig. 5Ab), and
Robo (Fig. 5Ac) shows that Nrx IV protein is concentrated at the
boundaries between the MG and the neuronal soma and is also
expressed in the lateral CNS (Fig. 5Aa,Ad) (Wheeler et al., 2009),
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while Slit localizes mostly in the MG and appears diffuse in the
commissural tracts (Fig. 5Ab,Ad) (Kidd et al., 1999). Robo local-
ization is as described in Figure 3. Earlier studies have shown that
Slit protein is synthesized in the MG and is eventually associated
with the surfaces of axons that traverse them (Rothberg et al.,
1990; Kidd et al., 1999). In nrx IV mutants, Slit is present in the
MG but Slit levels are qualitatively reduced (Fig. 5B), while in slit
mutants, the localization of Nrx IV in the ML is severely altered
(Fig. 5Ca, arrows) and Robo-positive axons show complete col-
lapse at the ML (Fig. 5Cc, arrowheads) (Kidd et al., 1999). In robo
mutants, Slit levels in MG are reduced and show a punctate distri-
bution and aberrant localization compared with the wild-type em-
bryos (Fig. 5Db, arrows). The altered localization of these proteins in
the mutant backgrounds of one another could be attributed to their
interdependence for proper localization or a disorganization of the
MG/neuronal cytoarchitecture. Immunostaining of stage 16 nrx IV,
robo, and slit mutant embryos against the MG-specific marker,
Wrapper, showed alterations in the MG organization (Fig. 5U–W,
respectively; compare with wild-type embryos in Fig. 5T) (Stork
et al., 2009; Wheeler et al., 2009). However it should be noted that
the changes in MG organization and architecture in robo and slit
mutants are thought to be secondary phenotypes that are mani-
fested during later stages of embryonic development (Kidd et al.,
1999).
The genetic analysis of robo and nrx IV prompted us to also
test for genetic interactions between nrx IV and slit. To analyze
the severity and range of the phenotypes in various transallelic
combinations of slit and nrx IV, we generated slit2/CyO;nrx
IV4304/TM6 flies and used BP102 (Fig. 5E–K) and Fas II (Fig.
5L–R) as phenotypic readouts. Wild-type embryos show a
ladder-like arrangement of axon trajectories in the CNS upon
staining with BP102 (Fig. 5E). nrx IV mutants show thinning of
LCs and fused commissures in some of the segments (Fig. 5F,
arrow). slit mutants, on the other hand, show a complete collapse
of axons at the ML (Fig. 5G). Transheterozygotes for slit and nrx
IV display partially fused commissures (Fig. 5H, arrows) when
compared with the wild-type embryos (Fig. 5E). There is a strong
enhancement of BP102 phenotype when one copy of slit is re-
moved from homozygous nrx IV mutants (Fig. 5I) as most seg-
ments have completely fused commissures (arrows) and thinner
LCs. Embryos of slit/;nrx IV/ (Fig. 5J) and double mutants
slit/;nrx IV/ (Fig. 5K) show a complete collapse of all axons
in the ML similar to those of slit mutants (Fig. 5G). The BP102
phenotype in various genetic backgrounds (Fig. 5E–K) indicates
that nrx IV and slit display genetic interactions.
We next studied the profile of Fas II trajectories in various
genotypic combinations of slit and nrx IV (Fig. 5L–R). Wild-type
embryos display three Fas II-positive fascicles on each side of the
ML (Fig. 5L). nrx IV mutants showed abnormal crossing of the
innermost Fas II-positive fascicles (Fig. 5M, arrows). Homozy-
gous slit2 embryos showed a characteristic collapse of CNS axon
scaffold onto the ML (Fig. 5N) (Kidd et al., 1999). Embryos het-
Figure 4. Genetic interactions between nrx IV and robo. A–N, Fas II (A–G) and BP102 (H–N ) expression in wild-type (A, H ), nrx IV (B, I ), robo (C, J ), robo/;nrx IV/ (D, K ), robo/;nrx IV /
(E, L), robo /;nrx IV/ (F, M ), and robo /;nrx IV / (G, N ) embryos. Arrows indicate crossing axons (B–E) and fused commissures (I, J, L). O, Quantitative analyses of FAS II axons crossing
the midline in various genotypic combinations (A–G). The asterisk(s) denotes the significance between the genotypes in comparison. P, Q, ap-Gal4::UAS-tauGFP (P) and ap-Gal4::UAS-tauGFP;nrx
IV / (Q) embryos expressing Robo (Pa, Qa), GFP (Pb, Qb), and Nrx IV (Pc, Qc, blue).
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erozygous for slit and nrx IV showed some segments with Fas
II-positive ipsilateral axons inappropriately crossing the ML (Fig.
5O, arrow). We next examined the effect of removing one copy of
slit on the nrx IV phenotype and found that slit dominantly en-
hances the nrx IV phenotype as increased number of axons cross
and circle the ML and the phenotype resembles that of the robo
mutants (Fig. 5P, arrows, compare with M; also see Fig. 5S). Such
a dosage-dependent increase in the sever-
ity of phenotype is a strong indication that
Nrx IV and Slit likely function in the same
pathway. It is important to note that slit
heterozygotes do not display any axon
guidance phenotypes (Kidd et al., 1999).
Removal of one copy of nrx IV does not
cause any noticeable change in the already
severely affected Fas II-positive tracts in
slit mutants (Fig. 5Q). Similarly, double
mutants of both slit and nrx IV resemble
the slit-null phenotype (Fig. 5R,S). To-
gether, these data indicate that mutations
in nrx IV and slit show strong genetic in-
teractions in modulating the ML repul-
sion phenotypes and that the subcellular
localization of Slit and Nrx IV is severely
altered in nrx IV and slit mutants,
respectively.
Nrx IV, Robo, and Slit exist as a
molecular complex
To test whether the protein colocalization
and genetic interactions observed be-
tween Nrx IV, Robo, and Slit reflect in vivo
biochemical changes and interactions be-
tween these proteins, we performed im-
munoblot (IB) and co-IP analyses. We
analyzed equal amounts of total proteins
in embryonic extracts from identically
processed COPAS-sorted wild-type and
nrx IV, robo, and slit homozygous mutant
embryos (see Materials and Methods) by
immunoblotting to determine changes in
protein levels. All mutant embryo collec-
tions were manually checked for any con-
taminating twi-GFP-expressing embryos
(sorting efficiency close to 100%) before
they were processed for biochemical anal-
yses. In robo mutants, Nrx IV levels were
significantly reduced, and in slit mutants,
Nrx IV levels were slightly increased (Fig.
6Aa). In nrx IV and slit mutants, Robo
levels were slightly reduced (Fig. 6Ab). In
nrx IV and robo mutants, Slit levels were
unchanged or slightly reduced, respec-
tively (Fig. 6Ac). In slit mutants, some
Slit protein persists likely due to mater-
nal contribution (Fig. 6 Ac) (Furrer et
al., 2007), but immunostaining of slit
embryos shows no detectable Slit pro-
tein in the ML (Fig. 5Cb). Immunoblot-
ting against -tubulin was used as a protein
loading control (Fig. 6Ad). These data in-
dicate that loss of Robo and Slit exert
opposite effects on the steady-state lev-
els of Nrx IV, further strengthening the genetic interaction
observations presented earlier.
Next we wanted to establish whether Nrx IV, Slit, and Robo
form an in vivo biochemical complex. As shown in Figure 6B,
both Robo (Fig. 6Bb) and Slit (Fig. 6Bc) are present in IP com-
plexes with anti-Nrx IV antibodies with wild-type embryonic
lysates. IP complexes from nrx IV mutants with anti-Nrx IV an-
Figure 5. Subcellular localization of Nrx IV in slit mutants and genetic interactions between nrx IV and slit. A–D, Wild-type (A),
nrx IV (B), slit (C), and robo (D) embryos show localization of Nrx IV (Aa, Ba, Ca, Da), Slit (Ab, Bb, Cb, Db), and Robo (Ac, Bc, Cc, Dc).
E–R, BP102 (E–K ) and Fas II (L–R) expression in wild-type (E, L), nrx IV (F, M ), slit (G, N ), slit/; nrx IV/ (H, O), slit/; nrx
IV / (I, P), slit /;nrx IV/ (J, Q), and slit /;nrx IV / (K, R) embryos. S, Quantitative analyses of the axon crossing
phenotypes in nrx IV, slit, and various transallelic combinations (L–R). T–W, Stage 16 wild-type (T ), nrx IV (U ), robo (V ), and slit
(W ) embryos show Wrapper localization in MG.
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tibodies do not show presence of Robo
and Slit (Fig. 6Bb,Bc) thus confirming the
specificity of IPs. Similarly, Nrx IV and
Slit are present in IP complexes with anti-
Robo antibodies from the wild-type em-
bryos and not from the robo mutants (Fig.
6Ca–Cc). IPs using anti-Slit antibodies
show the presence of Nrx IV and Robo
from the wild-type lysates and not from
the slit mutants (Fig. 6Db,Dc). Note that
some Slit protein is present in IPs from the
slit mutants but this does not seem to be
sufficient to IP Nrx IV and Robo from slit
mutants. The molecular interactions be-
tween Nrx IV, Robo, and Slit were also
observed in IP complexes with S2 cell ex-
tracts (see below). Together, these data
strongly indicate that Nrx IV, Robo, and
Slit form an in vivo biochemical complex.
Having established that Nrx IV, Robo,
and Slit exist in a molecular complex, we
next wanted to determine whether loss of
any one of these proteins results in the
breakdown of this molecular complex in
vivo. We performed IPs using embryonic
lysates from COPAS-sorted wild-type and
nrx IV, robo, and slit mutants. As shown in
Figure 6, Ea and Eb, loss of Nrx IV does
not abolish the binding of Robo and Slit,
as Slit is present in the Robo IP complex,
although Slit levels in the IP complex are
reduced compared with wild-type levels.
Similarly, loss of Robo does not abolish
the complex formation between Slit and
Nrx IV (Fig. 6Fa,Fb), although the levels
of Nrx IV are reduced in robo mutants
(Fig. 6Fa). In slit mutants, loss of Slit does
not disrupt interactions between Nrx IV
and Robo (Fig. 6Ga,Gb). This was further
confirmed by using slit RNAi in S2 cells.
RNAi against slit showed essentially no
detectable Slit protein in S2 cells (Fig.
6Ha, compare lane sli RNAi Lys with lane
Con Lys). IPs using anti-Nrx IV antibod-
Figure 6. Nrx IV forms a biochemical complex with Robo, Slit, and Sdc. A, Western blots from equal amounts of whole embry-
onic lysates from wild-type and nrx IV, robo, and slit mutant embryos were immunoblotted for Nrx IV (155 kDa) (Aa), Robo (180
kDa) (Ab), Slit (190 kDa) (Ac), and -tubulin (55 kDa) (Ad). Nrx IV levels in robo seem to be comparatively lower than those in the
wild-type and the slit mutant embryos (Aa). Robo levels are lower in nrx IV and slit mutants (Ab). Slit levels in nrx IV are comparable
to the wild type, while being lower in the robo mutant (Ac). While there is complete lack of Nrx IV and Robo from nrx IV (Aa) and
robo (Ab) mutants, respectively, slit mutants show presence of low level of Slit (Ac). B–D, Wild-type and nrx IV (B), robo (C), and slit
(D) mutant embryonic lysates were immunoprecipitated with anti-Nrx IV (B), anti-Robo (C), and anti-Slit (D), respectively. Wild-
type IPs show the presence of Nrx IV (Ba, Cb, Db), Robo (Bb, Ca, Dc), and Slit (Bc, Cc, and Da). nrx IV mutant IPs with anti-Nrx IV
antibodies do not show the presence of Nrx IV (Ba), Robo (Bb), and Slit (Bc). robo mutant IPs with anti-Robo antibodies do not
show the presence of Robo (Ca), Nrx IV (Cb), and Slit (Cc). slit mutant IPs with Slit antibodies show traces of Slit protein (Da) but do
not show detectable levels of Nrx IV (Db) or Robo (Dc). E–G, IPs from the wild-type and nrx IV, robo, and slit mutant embryos show
4
that loss of any one of these proteins does not abolish the
complex formation between the remaining two proteins.
(Note the breaks in panels are due to removal of irrelevant
lanes). H, Equal amounts of control S2 cells and cells treated
with slit dsRNA show presence of Slit in control, while com-
plete lack of Slit in the slit RNAi knock down cells (Ha). The
same blot was probed with anti--tubulin as a loading control
(Hb). I, IPs from control S2 and slit RNAi cells show that in the
absence of Slit, Nrx IV, and Robo still associate in a complex,
although less efficiently compared with controls. J, Immuno-
precipitation from wild-type embryo reveals the presence of
Nrx IV and Sdc in the same complex. K, Equal amounts of wild-
type and sdc10608 and Df48ubi-Sara homozygous embryos show
the presence of Sdc protein (Ka), unchanged levels of Nrx IV
(Kb), and -tubulin as control (Kc). L, M, The specificity of Sdc
antibody is established by IPs using anti-Nrx IV antibodies in
the wild-type and nrx IV mutant embryos (L) and Robo anti-
bodies in the wild-type and robo mutant embryos (M).
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ies with slit RNAi S2 cell extracts showed
the presence of reduced levels of Robo
(Fig. 6 I) compared with the control
lysates, indicating that Robo and Nrx IV
interact in the absence of Slit. These data
suggest that loss of any one of these pro-
teins does not abolish the complex forma-
tion between the two remaining proteins
and support the idea that the Nrx IV/
Robo/Slit signaling complex may exist as a
macromolecular complex with other mo-
lecular components.
Since HSPG Sdc is one such protein
that exists in a molecular complex with
Robo and Slit (Johnson et al., 2004), we
wanted to test whether Sdc and Nrx IV are
also in the same complex. IP with anti-Sdc
from wild-type embryonic lysates showed
the presence of Nrx IV (Fig. 6 J). The spec-
ificity of Sdc antibody was determined by
carrying out IPs with anti-Nrx IV anti-
bodies from wild-type and nrx IV mu-
tants. Sdc was detected only in the
wild-type and not in nrx IV mutant lysates
(Fig. 6L). Similarly Sdc was detected in IPs
with anti-Robo antibodies from the wild-
type and not the robo mutant lysates (Fig.
6M). We also analyzed sdc mutants by IB
analysis against Sdc and Nrx IV. As shown
in Figure 6K, in two independent sdc mu-
tants, Sdc levels were slightly reduced but
not absent compared with the wild type
because of significant amounts of the ma-
ternal Sdc protein (Johnson et al., 2004)
(Fig. 6Ka). The Nrx IV protein levels were
not affected in either sdc mutant (Fig.
6Kb). Furthermore, no significant alter-
ation in the subcellular localization of Nrx
IV was observed in sdc mutants (supple-
mental Fig. S4, available at www.
jneurosci.org as supplemental material).
Together, the biochemical analyses indi-
cate that Nrx IV is an essential component
of the Robo/Slit protein complex and that
loss of any of the components does not
abolish the formation of the complex but
reduces the efficacy of the complex forma-
tion between the remaining components.
Nrx IV and Robo colocalize and
interact in a heterologous system
The axonal localization (Fig. 3) and in vivo
biochemical association (Fig. 6) of Nrx IV
and Robo suggest that these proteins in-
teract in cis within the plasma membrane.
To further confirm the cis interaction, we
examined the subcellular localization and
biochemical association of Nrx IV and
Robo in a heterologous system. We trans-
fected robo and nrx IV, either separately or
together, into mammalian CHO and HEK
293 cells. Both Nrx IV (Fig. 7A) and Robo
(Fig. 7B) localize to intracellular vesicles
Figure 7. Nrx IV and Robo interact in a heterologous system. A, B, nrx IV (A) and robo (B) localize to both plasma membrane and
intracellular compartments in transfected CHO cells. C, Mock-transfected cells stained with Nrx IV and Robo antibodies show
undetectable levels of either protein. D, E, The distribution of nrx IV (Da, Ea) and robo (Db, Eb) overlap in cotransfected CHO cells
both in the absence (D) and presence (E) of Slit-conditioned medium. F, The distributions of nrx IV (Fa) and cont (Fb) also overlap
in cotransfected CHO cells. G–J, Western blot analyses of wild-type embryonic (Emb /) and transfected HEK 293 cells. Cells
transfected with Nrx IV (G), Robo (H), Slit (I), and Cont (J) express polypeptides with the same apparent molecular weight seen in
embryonic lysates. These bands are not detected in mock-transfected cells (). K, M, Nrx IV and Robo myc co-IP from cotransfected
HEK 293 cells immunoprecipitated with either anti-Nrx IV (K) or anti-Myc (M). L, N, O, Control experiments: HEK 293 cells trans-
fected with robo (L), nrx IV (N), or Ecad (O) and immunoprecipitated with anti-Nrx IV (L, O) or anti-Myc (N) antibodies showed no
detectable levels of Robo (L), Nrx IV (N), or Ecad (O) in IPs. P, Positive control: Cont coprecipitates with Nrx IV in cotransfected HEK
293 cells.
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and the cell membrane in CHO cells. Lit-
tle if any staining was detected in mock-
transfected cells stained with antibodies
against these two proteins (Fig. 7C). In
CHO cells cotransfected with nrx IV (Fig.
7Da) and robo (Fig. 7Db), the proteins
colocalize within intracellular vesicular
compartments (Fig. 7Da–Dc, arrows) and
the cell plasma membrane (Fig. 7Da–Dc,
arrowheads). Since earlier studies have
shown that Slit binding to the Robo recep-
tor can recruit cytosolic effectors like PAK
and Dock (Wong et al., 2001; Fan et al.,
2003), we also examined whether Slit stim-
ulation had any effect on the overlapping
distribution of Nrx IV and Robo in cotrans-
fected CHO cells. As demonstrated in Fig-
ure 7E, the staining of both Nrx IV (Fig.
7Ea) and Robo (Fig. 7Eb), processed and
imaged under identical conditions, shows
that the proteins still colocalize within the
cell membranes. Interestingly, both proteins
also showed increased colocalization in
plasma membrane ruffles (Fig. 7Ec, arrow-
heads) and membrane extensions such as
filopodia (Fig. 7Ea–Ec, arrows). This colo-
calization is qualitatively similar to that
previously observed for Nrx IV and Con-
tactin (Fig. 7F), two well established bind-
ing partners (Faivre-Sarrailh et al., 2004).
These data indicate that Nrx IV and Robo
retain their ability to colocalize in a non-
Drosophila cell system in the absence of
other Drosophila proteins.
We next addressed whether Nrx IV
and Robo could form a complex in mam-
malian cells, and whether addition of Slit
would enhance the complex formation.
Initially, HEK 293 cells were separately
transfected with pcDNA3.1 containing nrx
IV, robo, and slit cDNAs and processed for
IB analysis to confirm that the expressed
polypeptides were comparable in size to
the endogenous proteins from Drosophila
embryos. We found that Nrx IV (Fig. 7G),
Robo (Fig. 7H), and Slit (Fig. 7I) expressed in 293 cells had the
same apparent molecular weight as the correlating embryonic
proteins (Fig. 7G–I, Emb), suggesting that the expression of these
Drosophila proteins in mammalian cells did not interfere with
their processing or post-translational modifications. The same
was true for cont transfected 293 cells (a positive control) (Fig. 7J)
(Faivre-Sarrailh et al., 2004). Mock-transfected 293 cells did not
show detectable levels of any of these Drosophila proteins (Fig.
7G–J, lanes marked as ). We next analyzed the interaction be-
tween Nrx IV and Robo myc (Bashaw et al., 2000) in absence and
presence of Slit treatment by immunoprecipitating either Nrx IV
(Fig. 7K) or Myc (Fig. 7M) from 293 cells cotransfected with both
nrx IV and robomyc. We found that both Robo and Nrx IV were
detected in IPs with anti-Nrx IV (Fig. 7K) and anti-Myc (Fig.
7M), respectively, confirming that Nrx IV and Robo interact in a
heterologous system. Slit treatment of nrx IV- and robomyc-
cotransfected 293 cells did not seem to enhance the coprecipita-
tion of Nrx IV and Robo. We were unable to co-IP Robo (Fig. 7L),
Nrx IV (Fig. 7N), or the adhesion molecule E-cadherin (Ecad)
(Fig. 7O) from transfected 293 cells with either Nrx IV (Fig.
7L,O) or Myc (Fig. 7N) antibodies, indicating that the observed
IP of Nrx and Robo was highly specific. However, we were able to
co-IP the known binding partners Nrx IV and Cont from nrx IV-
and cont-cotransfected 293 cells with anti-Nrx IV antibodies (Fig.
7P) (Faivre-Sarrailh et al., 2004). These studies support our in
vivo findings by demonstrating that Nrx IV and Robo can form a
molecular complex in a heterologous system.
Robo localization and midline axon guidance function
requires the extracellular domain of Nrx IV
The cytoplasmic regions of many transmembrane receptor proteins
play key roles in signal transduction by interacting with intracellular
proteins. Since Robo is a transmembrane receptor for Slit and colo-
calizes and biochemically interacts with Nrx IV, we wanted to know
whether Nrx IV plays a direct role as a signal transducer independent
of or alongside Robo. Nrx IV being a transmembrane protein with a
Figure 8. The extracellular domain of Nrx IV is sufficient to rescue the midline axon guidance phenotype and Robo localization.
A–D, Wild-type, (A) nrx IV (B), elav-Gal4::UAS-nrx IVmycCT;nrx IV / (C), and elav-Gal4::UAS-nrx IVmycNT;nrx IV / (D) em-
bryos expressing Nrx IV (A, B, D, green), Fas II (A, B, D, red), and Myc (C, green) and Fas II (C, red). E–H, Robo localization in
wild-type (E), nrx IV (F), elav-Gal4::UAS-nrx IVmycCT;nrx IV / (G), and elav-Gal4::UAS-nrx IVmycNT;nrx IV / (H) embryos.
I, Quantification of ML axon guidance phenotypes from each of the above genotypes (A–D) shows significant rescue in
elav-Gal4::UAS-nrx IVmycCT;nrx IV / embryos compared with nrx IV mutants alone. J, Diagram illustrating the domain struc-
tures of Nrx IV, Robo, and Slit proteins. Robo has an ectodomain with five Ig domains, three fibronectin (FN) III repeats, transmem-
brane (TM), and a long cytoplasmic tail containing domains CC0 to CC3. Slit contains a signal peptide (SP), four tandem leucine-rich
repeats (LRRs), epidermal growth factor (EGF) repeats, a conserved laminin G spacer also found in Nrx IV, laminin, agrin, and
perlecan, and a C-terminal cysteine knot (CK). Nrx IV has an SP, discoidin (DC), laminin G (LG), EGF repeats, a TM and a short
C-terminal tail. GPI, Glycosylphosphatidylinositol.
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large extracellular region and a short cytoplasmic domain, we set out
to determine whether Nrx IV lacking the cytoplasmic domain would
be able to rescue the axon guidance phenotype. To accomplish this,
we generated two independent transgenic fly lines with UAS con-
structs that expressed myc-tagged truncations of Nrx IV protein
(Fig. 8J) in which either the transmembrane and the intracellular
region was replaced with a glycosylphosphatidylinositol anchor
(Nrx IV mycCT) or the extracellular region was deleted (Nrx
IV mycNT). In wild-type embryos, Nrx IV localization is in the
CNS (Fig. 1) and Fas II expression is seen in ipsilaterally project-
ing axons (Fig. 8A). Robo localization is at high levels in the
longitudinally projecting axons and low in the commissural
tracts (Fig. 8E). nrx IV mutants show complete loss of Nrx IV
protein as expected and the typical Fas II axonal phenotype in the
ML (Fig. 8B, arrows). Robo localization in nrx IV mutants is
diffused and Robo-positive axons are found to cross and collapse
at the ML (Fig. 8F, arrows). Expression of UAS-nrx IVmycCT with
elav-Gal4 in nrx IV mutants significantly rescued the Fas II cross-
ing as well as Robo localization phenotypes (Fig. 8C,G, respec-
tively; Fig. 8 I) compared with homozygous nrx IV mutants (Fig.
8B,F). Expression of elav-Gal4::UAS-nrx IVmycNT in nrx IV mu-
tants failed to rescue either the Fas II axon crossing (Fig. 8D,
arrows) or the Robo localization phenotypes (Fig. 8H, arrows;
Fig. 8 I). These data indicate that the formation of the Nrx IV/
Robo/Slit complex and the axon guidance function of Nrx IV
reside in the extracellular region of the protein and that the cyto-
plasmic region is dispensable for this function. These data also
suggest that Nrx IV might not act as a signal transducer but rather
functions to allow proper localization and stability of Robo and
formation of a macromolecular signaling complex that involves
Nrx IV, Robo, Slit, and other associated proteins for efficient
repulsive ML axon guidance.
Discussion
Here, we have provided in vivo genetic, cell biological, and bio-
chemical evidence that Nrx IV functions in ML repulsion of ax-
ons and through its interactions with Robo to ensure proper
Robo localization in the embryonic CNS. Furthermore, we show
that Nrx IV and Robo retain their ability to colocalize and interact
in a heterologous cell system, reaffirming their functional inter-
actions. Together, these data provide new insights into the addi-
tional roles of Nrx IV outside the realm of SJs and identify Nrx IV
as an important interacting partner of the Slit/Robo signaling
complex during ML repulsion.
Varied patterns of Nrx IV localization in the CNS underscore
different functions
Recent studies from our laboratory and others have established
strong expression of Nrx IV at the interface between neurons and
MG that underlies the adhesive interactions between these cells in
maintaining ML cytoarchitecture. This function of Nrx IV is
Wrapper dependent (Stork et al., 2009; Wheeler et al., 2009). We
believe that the axon guidance function of Nrx IV is Wrapper inde-
pendent based on the following observations. First, the juxtaposition
of strong neuronal Nrx IV and glial Wrapper in the ML, together
with the absence of axon guidance phenotype in wrapper mutants
(Fig. 2) strongly suggests that Nrx IV localization in ML neurons
does not contribute to the axon guidance function of Nrx IV. This is
further supported by the failure to rescue the axon guidance pheno-
types in nrx IV mutant by expressing Nrx IV in all ML neurons and
glia with sim-Gal4::UAS-nrx IV (Fig. 1). Therefore, a significant
contribution of the axon guidance phenotype seen in nrx IV mu-
tants is unlikely to come from ML neurons or glia. Interestingly,
the MG ensheathment defects seen in nrx IV mutants are rescued
by expression of Nrx IV in neurons alone and not MG (Wheeler
et al., 2009). Furthermore, no changes in Robo localization or
crossing of Robo-positive axons were seen in wrapper mutants,
thus providing additional evidence that alterations in MG/neu-
ronal architecture in wrapper mutants does not significantly con-
tribute to the axon guidance phenotype (data not shown). Of
note, older stage 16 robo and slit mutants show considerable dis-
organization of MG, as revealed by immunostaining with anti-
Wrapper antibodies (Fig. 5); however, these glial phenotypes are
thought to be secondary to their axon guidance phenotypes. In
addition, Cont and Nrg, two well established binding partners of
Nrx IV at SJs, do not contribute to Nrx IV in its CNS axon guid-
ance function, as revealed by Fas II immunostaining of cont and
nrg mutants (supplemental Fig. S2, available at www.jneurosci.
org as supplemental material). Based on these observations, we
believe that Nrx IV is a multifunctional protein that functions in
a cell-type-specific manner. Therefore, the axon guidance func-
tion of Nrx IV is to ensure proper localization and stability of
Robo in the lateral CNS soma and axons during ML axon
repulsion.
Additional support for tissue-specific functions of Nrx IV
comes from recent reports that Drosophila cardiac development
uses a noncanonical role of Nrx IV to maintain cardiac integrity,
by coupling with G-protein signaling (Yi et al., 2008). Both Robo
and Slit have previously been shown to control cardiac cell polar-
ity and morphogenesis (Qian et al., 2005; Santiago-Martínez et
al., 2008). Since embryonic heart cells lack SJs, these findings
further underscore the fact that Nrx IV and Robo/Slit coordinate
diverse roles in different tissues involving multiple molecular
partners. Thus, Nrx IV functions in Slit/Robo axon guidance
pathway independently of its other known partners, such as
Cont, Nrg, and Wrapper.
Molecular complex of Nrx IV, Robo, and Slit: direct and
indirect interactions
Our findings strongly support the existence of Nrx IV, Robo, and
Slit as a molecular complex. Although Nrx IV function appears
interwoven with Robo and Slit, the phenotypes displayed by nrx
IV mutants do not completely phenocopy either slit or robo mu-
tants, suggesting that Nrx IV plays a modulatory role in Slit/Robo
signaling. The biochemical analyses suggest that Robo is required
for Nrx IV stability, as the levels of Nrx IV are significantly reduced in
robo mutants (Fig. 6A,F). Slit, on the other hand, showed a modest
stimulatory effect on Robo and Nrx IV association and expression
levels, further confirming that these three proteins are functionally
interlinked. Furthermore, the Slit/Robo complex is less efficiently
immunoprecipitated from nrx IV mutants (Fig. 6E). Thus, while loss
of Nrx IV does not abolish interactions between Robo and Slit, it
could potentially affect proper functioning of the Robo/Slit signaling
complex. Similarly, reduced association of Slit and Nrx IV in robo
mutants suggests that Robo is also important for efficient complex
formation between these three proteins.
Both Nrx IV and Robo are transmembrane proteins that co-
localize in longitudinal axons. Most of the known Nrx IV-
interacting proteins, such as Cont, Nrg, and Wrapper, belong to
Ig superfamily of cell adhesion molecules (CAMs) (Tessier-
Lavigne and Goodman, 1996). Therefore, it is conceivable that
Nrx IV associates with Robo (an Ig CAM) in neurons that do not
express detectable levels of Cont or Wrap. Furthermore, nrx IV
mutant phenotypes resemble those of robo mutants (Fig. 1 Jb),
and Nrx IV interacts with Robo/Slit, suggesting that Nrx IV func-
tions in the Robo/Slit pathway.
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Recent studies support a model in which Slit stimulation re-
cruits cytoplasmic Sos to Robo receptor via Dock to activate Rac-
dependent cytoskeletal changes within the growth cone during
repulsion (Yang and Bashaw, 2006). We show that Nrx IV and
Robo retain their ability to colocalize and interact when coex-
pressed in a heterologous system and indicate that Slit is dispens-
able for their interaction. In addition, slit RNAi experiments in S2
cells reveal that Nrx IV and Robo associate in the absence of Slit.
However, Slit stimulation of nrx IV/robo cotransfected CHO cells
caused enhanced colocalization of Nrx IV and Robo in intracel-
lular compartments and membrane ruffles, further supporting a
functional relationship between Nrx IV and Robo/Slit (Fig. 7).
Together, our in vivo and in vitro findings indicate that Nrx IV
and Robo interact in the absence of Slit, and in the presence of Slit
ligand the molecular interactions between Nrx IV and Robo are
strengthened. Formation of this larger molecular complex at the
axonal surface thus ensures proper ML axon guidance.
Nrx IV: modulator of Robo/Slit signaling
The phenotypic similarities, dose-dependent genetic interac-
tions, and in vivo biochemical data suggest that Nrx IV acts as a
modulator in Slit/Robo signaling pathway. One of the key reasons
for this conclusion is the fact that the axon guidance phenotypes
in nrx IV mutants are rescued by the expression of the extracel-
lular region of Nrx IV (Nrx IV mycCT), and this phenotype is not
rescued by the intracellular region of Nrx IV (Nrx IV mycNT). For
Nrx IV to act as an independent signal transducer, it would need
an intact cytoplasmic region. Since the axon guidance pheno-
types and Robo localization (Fig. 8) are both rescued by Nrx
IV mycCT, the downstream signaling controlling axon repulsion
is controlled by Robo or an as-yet-unidentified protein. There-
fore, our data support a role for Nrx IV in the proper localization
and stabilization of Robo at axonal membrane, where it interacts
with Slit, to regulate downstream axon guidance signaling. Al-
though the exact domains regulating Nrx IV–Robo interactions
are unknown at this point, we predict that they occur via the Ig or
FNIII domains, as these domains regulate Nrx IV–Cont interac-
tions. Our data rule out the possibility that Nrx IV interactions
with Robo occur via a large cytoskeletal scaffolding complex, as
Nrx IV mycCT lacks the cytoplasmic region. This allows us to
conclude that Nrx IV and Robo interact in cis through their ex-
tracellular regions and therefore to eliminate the possibility of a
parallel Nrx IV signaling pathway.
One of the interesting in vivo observations is the association
between Nrx IV and Slit still occurs in robo-null mutant embryos,
indicating that Slit/Nrx IV can interact in the absence of Robo.
Although it remains to be seen whether Nrx IV and Slit can asso-
ciate in the absence of all Drosophila proteins in a heterologous
system, based on the existing findings it is tempting to speculate
that Nrx IV may function as a coreceptor for Slit, and together
with Robo, they stabilize the complex to ensure proper presenta-
tion or retention at the axonal surface. A similar role has been
assigned to Sdc, which is thought to be critical for the fidelity of
Slit repellent signaling, as sdc mutants exhibit consistent defects
in ML axon guidance (Johnson et al., 2004; Steigemann et al.,
2004; Furrer et al., 2007). Thus, a multitude of mechanisms seem
to operate at the axonal surface and growth cones to ensure that
axons reach their correct targets (Spitzweck et al., 2010). The
Slit-independent interactions between Nrx IV and Robo, but
seemingly enhanced colocalization and interactions in the pres-
ence of Slit, point to an interesting mechanism whereby signaling
molecules use accessory proteins to ensure their proper localiza-
tion and stability. This mechanism ensures checks and balances at
several molecular levels to allow navigating axons to reach their
final destinations. To our knowledge, very few proteins have been
implicated in Slit/Robo signaling at the axonal surface, and addi-
tional yet-unidentified proteins may be involved. With the iden-
tification of Nrx IV as an essential component of the Slit/Robo
complex, new insights into this highly sophisticated molecular
pathway are opened, and this may allow future studies aimed at
identifying the modulatory proteins that coordinate and/or con-
trol axon guidance.
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